Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

Condition:   Colorectal Neoplasms Intervention:   Drug: Pemetrexed & S-1 & Bevacizumab Sponsors:   The First Affiliated Hospital with Nanjing Medical University;   Jiangsu HanSoh Tharmaceutical Group Co., Ltd Not yet recruiting

Source: ClinicalTrials.gov - February 18, 2019 Category: Research Source Type: clinical trials